Organ transplant recipients receiving immunosuppression show a dramati
cally increased risk of non-melanoma skin cancer. The cause of this in
crease is not known. We report that the rate of loss of heterozygosity
(at all the loci we examined) was significantly lower in tumours from
immunosuppressed individuals than in tumours from immunocompetent sub
jects [20 out of 148 (14%) vs 157 out of 428 (37%);P < 0.0001]. These
results suggest that tumours in immunosuppressed individuals have a di
fferent molecular pathogenesis.